Detalhe da pesquisa
1.
Randomized Bendamustine-Rituximab(R) + Bortezomib Induction and R + Lenalidomide Maintenance for Mantle Cell Lymphoma.
Blood
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820500
2.
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial.
Blood
; 135(25): 2224-2234, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232481
3.
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study.
Haematologica
; 107(7): 1633-1642, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407602
4.
Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure.
Mol Psychiatry
; 26(10): 5940-5954, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32094584
5.
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
Blood
; 132(10): 1013-1021, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049811
6.
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.
J Urol
; 201(2): 322-331, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30179618
7.
FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.
Oncology (Williston Park)
; 31(1): 45-9, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28090622
8.
FDG-PET for Early Response Assessment in Lymphomas: Part 2-Diffuse Large B-Cell Lymphoma, Use of Quantitative PET Evaluation.
Oncology (Williston Park)
; 31(1): 71-76, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28090627
9.
The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease.
Blood
; 124(23): 3356-64, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25428223
10.
The Mount Sinai clinical pathway for the management of pheochromocytoma.
Endocr Pract
; 21(4): 368-82, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25297659
11.
Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?
Blood
; 120(25): 4913-20, 2012 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22932799
12.
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale.
Haematologica
; 99(6): 1107-13, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658820
13.
Current role of FDG PET/CT in lymphoma.
Eur J Nucl Med Mol Imaging
; 41(5): 1004-27, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24519556
14.
FDG-PET imaging for Hodgkin lymphoma: current use and future applications.
Clin Adv Hematol Oncol
; 12(1): 20-35, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25000313
15.
Automated Lugano Metabolic Response Assessment in 18F-Fluorodeoxyglucose-Avid Non-Hodgkin Lymphoma With Deep Learning on 18F-Fluorodeoxyglucose-Positron Emission Tomography.
J Clin Oncol
; : JCO2301978, 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38843483
16.
A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701.
Cancer
; 119(21): 3797-804, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23922187
17.
Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.
Oncologist
; 18(10): 1108-17, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24037978
18.
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.
Blood
; 117(20): 5314-20, 2011 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21355087
19.
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance).
J Clin Oncol
; 41(5): 1023-1034, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269899
20.
A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials.
EJHaem
; 4(4): 1042-1051, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38024624